April Pride podcast

137. Is MDMA safe after age 70?

3/11/2026
0:00
27:02
Manda indietro di 15 secondi
Manda avanti di 15 secondi

A psychotherapist and his wife discuss 25 years of using MDMA together, testing it safely in today's drug supply, and what it taught them about grief.


🔵 Episode Summary

Is MDMA safe after 70? Charley and Shelley Wininger have used it together more than a hundred times over twenty-five years, and they joined me to make the case that it belongs to midlife and beyond at least as much as it belongs to a festival crowd in their twenties.

Charley is a licensed psychoanalyst and mental health counselor in Brooklyn, practicing since 1989, and the author of "Listening to Ecstasy: The Transformative Power of MDMA." Shelley is a retired critical care nurse. Neither of them treats this casually. We get into how they source and test MDMA, including a newer complication in drug checking that most listeners haven't heard of yet, and why the medications most people over sixty five are already taking change the entire experience and need a doctor in the conversation.

We also talk about what it's actually done for their marriage, a chapter Charley reads aloud from his book about mortality, and what happened when Shelley used MDMA with a group of forty people in a park nine days after her son died.

We are living through what public health researchers call an epidemic of isolation, and the Winingers' argument is a simple one: the antidote they found was not a program. It was each other, said plainly, a few times a year, for twenty five years.


🔵 Key Takeaways

  • Testing isn't one step anymore; it's two, maybe three. A reagent kit confirms MDMA is present. A fentanyl test strip checks separately for fentanyl. A newer class of synthetic opioid, chemically different from fentanyl and in some cases far more potent, won't show up on a fentanyl strip at all.
  • Roughly one in five women in their forties and fifties are on an antidepressant, and that share keeps climbing after sixty (CDC/NCHS, 2015–2018). These medications don't clear quickly, and timing MDMA around them is a conversation for a prescriber, not a solo decision.
  • A serotonin-recovery practice some people use after MDMA carries a real risk of serotonin syndrome if timed too close to the dose itself; harm reduction guidance calls for a minimum 24- to 48-hour wait.
  • Grief, not a diagnosis, is often what actually brings people to this medicine. Shelley's story is offered as one data point on that, not a treatment claim.
  • A twenty-five-year, 200-person community built on sober potluck dinners is the throughline of the Winingers' argument that MDMA's real value for this age group is connection, not escape.

🔵 Timestamps

0:00 Welcome and tonight's topic: MDMA after 70

0:00 Charley and Shelley's origin story, and the "useless medicine" years

2:00 The isolation epidemic and sourcing MDMA through community

3:00 Testing MDMA safely: what's changed in the drug supply

4:00 Why Shelley tried MDMA, and what it gave her that nothing else had

5:00 Charley reads "Senior High" from his book, and the mortality conversation

7:30 Medications, contraindications, and talking to your doctor first

14:00 Community, chosen family, and 25 years of potlucks

15:30 Shelley's story: a grief circle in the park, nine days after loss

19:00 The closing question every couple should bring into the room


🔵 Guest

Charley Wininger is a licensed psychoanalyst and mental health counselor based in Brooklyn, in practice since 1989, and the author of "Listening to Ecstasy: The Transformative Power of MDMA" (Park Street Press). Shelley Wininger is a retired critical care nurse. Together they've used MDMA more than a hundred times over twenty-five years. Follow Charley on Substack.


Psychedelic Salon at Town Hall Seattle: 2026-27 Schedule

Follow April on Substack

Visit aprilpride.com

Original Substack post


Hosted by April Pride

IG: @aprilpridecreates - https://instagram.com/aprilpridecreates

YouTube: https://youtube.com/@aprilpridecreates

Altri episodi di "April Pride"